Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer

Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer

Background: Centrosomal Protein 55 (CEP55) was initially described as a main participant in the final stage of cytokinesis. Further research identified CEP55 as a cancer-testis antigen (CTA) that is aberrantly expressed in different malignancies and a cancer vaccination candidate. The current study...

Full description

Bibliographic Details
Main Authors: Xiaodong Xie, Hongyin Liang, Wushuang Jiangting, Yu Wang, Xiao Ma, Zhen Tan, Long Cheng, Zhulin Luo, Tao Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Molecular Biosciences
Subjects:
CEP55
pan-cancer
prognostic biomarker
immunotherapy efficiency
CMAP
molecular docking
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2023.1198557/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2023.1198557/full

Similar Items